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Left ventricular remodeling and dysfunction
Pig
crospheres. Eight male domestic pigs (3 to 4 months old, 25 ± 2 kg)
were used in this study. Aspirin (2–3 mg/kg/d) was mixed in the food
3 days prior to experimental studies. All animals received humane
care and that study protocols comply with the institution's guidelines.
Pigs were anesthetized by an intramuscular injection of ketamine
(15 mg/kg) combining with atropine (1 mg) and then ﬁxed in a supine
position on the workstation, 3–5 ml 3% pentobarbital sodium solution
was injected via ear marginal vein on demand tomaintain the anesthe-
sia state. Oxygen saturation (SO2) was measured with pulse oximeter.
Anticoagulation was induced with 200 IU/kg heparin sodium. TheNo-reﬂow or slow-ﬂow post revascularization remains a challenge
in interventional cardiology. The “no-reﬂow” phenomenon is largely
induced bymicroemboli of atherosclerotic debris, spasm,microvascular
damage, and thrombi generated by percutaneous coronary intervention
(PCI) procedure [1]. Clinical studies revealed that patients exhibiting
no-reﬂow following reperfusion therapy for acutemyocardial infarction
(AMI) were associated with worse prognosis compared to patients
without no-ﬂow [1,2]. Currently, the mechanism of no-reﬂow has
been exclusively studied in animal models of coronary artery ligation/
reperfusion [5] and coronary microembolization (CME) [3–5] in canine
or pigmodels, as well as in the rat coronary autologous coronary throm-
botic microembolism model [6]. However, ischemia/reperfusion model
in pig and canine only partly reﬂects pathological changes of no-reﬂow,
since clinical “no-reﬂow” phenomenon is largely induced by
microemboli [1] but not induced by coronary artery occlusion. Recently,
Ma et al. reported that continuous injection of 120,000 42 μm micro-
spheres into the left anterior descending (LAD) did not induce changes
on coronary thrombolysis in myocardial infarction (TIMI) grade
and TIMI 3 coronary ﬂow was maintained immediately after
microembolization and hemodynamic parameters remained stable
before and after CME [7]. Till now, there is no large animal model
presenting angiographic evidence of slow ﬂow.pital, Puai Hospital, Huazhong
73#, QiaoKou District, Wuhan
4247.
land Ltd. This is an open access articlIn this study, we established an angiographic coronary slow ﬂow
model in pig by repeated coronary injection of small doses of 40 μmmi-
right femoral artery was dissected and a 6 F vascular sheath was placed
for arterial access. After initial coronary angiography (CAG) using 6 F
JR3.5 guiding catheter (Medtronic, Inc.), ventriculography and LV
pressure measurements with 5 F Pigtail catheter (Cordis Inc.), a 2.6 F
infusion microtubule catheter (Terumo Corporation) was then placed
at the middle part of the LAD artery for microsphere injection, and
0.1 ml stock solution with 12,000 microspheres was diluted in 5 ml
saline and injected for 20 s through the 2.6 F infusionmicrotubule cath-
eter; this procedure was repeated, followed by 2 × 0.2ml stock solution
diluted into 5 ml saline with 24,000 microsphere injection, then 0.3 ml
stock solution diluted into 5 ml saline with 36,000 microsphere injec-
tion (interval between each injection was 5 min) till the appearance
of angiographic slow ﬂow: TIMI frame count (TFC) N 40. LV pressures,
ventriculography and CAGweremeasured at baseline and 3 h and cath-
eters werewithdrawn and animals were allowed to recover. All animals
were fully recovered within 24 h and breathing spontaneously without
intubation. One pig developed dyspnea (SO2 = 70%) during the proce-
dure and recovered after 35 min mechanical respiration. Another pig
died of cardiac failure at second day post procedure. Intramuscular
analgesics (0.025 mg/kg IM butorphanol) were administered postoper-
atively as required to alleviate pain. Surviving animals (n = 7) were
re-anesthetized at 4 weeks post procedure for hemodynamic and CAG
examinations. LV end-diastolic volume and ejection fraction (LVEF)
were assessed with quantitative ventriculography by an experienced
investigator. The blood ﬂow in the LAD was assessed with the TIMI
scale and TFC (TIMI frame count) while myocardial tissue perfusion
was analyzed with the TMPG scale (TIMI myocardial perfusion grade)
[8]. Data were compared using the one-way analysis of variance
(ANOVA). P b 0.05 were considered statistically signiﬁcant.
The mean injected stock solution was 2.45 ± 0.52 ml (around
294,000 microspheres) to induce slow ﬂow in this model. Fig. 1 showse under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Representative coronary angiography (CAG) imaging at baseline (A, TIMI grade 3), immediately at the time of slow ﬂow formation (B, TIMI grade 2), 3 h (C, TIMI grade 2) and
4 weeks (D, TIMI grade 3) post microsphere injection. Anatomical marks: the farthest branch of anterior descending branch (LAD) which was deﬁned by the tail of the whale or grass
fork imaging.
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slow ﬂow formation, 3 h and 4 weeks post microsphere injection. As
shown in Table 1, TIMI ﬂow was reduced to grade 2 at the time of
slowﬂow formation and at 3 h postmicrosphere injection and TMPG re-
duced to grade 0.3 ± 0.5 at 3 h post microsphere injection, both
recovered to grade 3 at 4 weeks post microsphere injection. TFC was
signiﬁcantly increased at 3 h post microsphere injection and returned
to baseline level 4 weeks later. LVSP, dP/dtmax, dP/dtmin and LVEF
were signiﬁcantly reduced while LVEDP was signiﬁcantly increased at
3 h and 4 weeks post procedure compared to baseline values (allTable 1
Angiographic and hemodynamic parameters at baseline, 3 h and 4 weeks post LAD
coronary microsphere injection.
Baseline 3 h 4 weeks
TIMI (grade) 3 ± 0 2 ± 0⁎ 3 ± 0†
TMPG (grade) 3 ± 0 0.3 ± 0.5⁎ 3 ± 0†
TFC (frames) 15.8 ± 3.4 29.2 ± 9.1 ⁎ 18.2 ± 2.3†
LVSP (mmHg) 147 ± 15 113 ± 10⁎ 123 ± 9⁎
LVEDP (mmHg) 7.8 ± 3.6 15.1 ± 2.0⁎ 14.3 ± 1.2⁎
HR (beats/min) 129 ± 11 110 ± 7⁎ 124 ± 6†
dP/dtmax (mmHg/s) 2887 ± 204 2156 ± 162 ⁎ 2323 ± 209⁎
dP/dtmin (mmHg/s) −2417 ± 206 −2081 ± 246 ⁎ −2094 ± 334⁎
LVEDV (ml) 24.4 ± 3.3 25.3 ± 3.7 32.8 ± 4.2⁎†
LVESV (ml) 7.7 ± 1.5 11.6 ± 2.6⁎ 13.8 ± 3.0⁎
LVEF (%) 68 ± 5 55 ± 4⁎ 58 ± 5⁎
LAD: left anterior descending artery, TIMI: Thrombolysis in Myocardial Infarction, TMPG:
TIMI myocardial perfusion grade, TFC: TIMI frame count, LVSP: LV systolic pressure,
LVEDP, LV end-diastolic pressure, HR: heart rate, dP/dtmax: maximal rate of rise of LV
pressure, dP/dtmin: maximal rate of decline of LV pressure, LVEDV: LV end-diastolic
volume, LVESV (ml): LV end-systolic volume, LVEF: LV ejection fraction.
⁎ P b 0.05 vs. baseline.
† P b 0.05 vs. 3 h post LAD microsphere injection.p b 0.05). LV end-diastolic and end-systolic volumes were signiﬁcantly
increased at 4 weeks post injection compared to baseline level.
In this report, we presented angiographic slow ﬂow evidence in pigs
receiving repeated low-dose LAD microsphere injection. To our best
knowledge, this is the ﬁrst study reporting the angiographic evidence
of slow ﬂow in the large animal model.
The average of amount of LAD injected microspheres was about
294,000, which is 2 to 3 folds higher than previous reported amount
used in the pig CME model without affecting TIMI grade (n =
120000)10, suggesting that a larger amount of LAD microsphere injec-
tion is needed to induce slow ﬂow phenomenon in the pig. Repeated
low-dose LAD microsphere injections beginning with 12,000 micro-
spheres (which was only the 1/10th dose used in the previous
study10) and followed by 24,000, then 36,000microspheres are success-
ful to induce angiographic slow ﬂow. Repeated small amount LAD
microsphere injections could be viewed as a kind of “ischemic precon-
ditioning” [9], which might help to minimize the risk of developing
malignant lethal arrhythmias and increase the tolerance of pigs to the
larger amount of LAD microsphere injection needed to form angio-
graphic slow ﬂow. Despite the recovery of TIMI, TMPG and TFC values
to baseline level, LV remodeling and dysfunction were still visible at
4 weeks post procedure, suggesting that this slow ﬂow model mim-
icked to some extent the clinical situation of patients with no-reﬂow
post PCI procedure. Thus, this model might support investigation on
underlying mechanisms and new therapy options for slow ﬂow or
no-reﬂow.Conﬂict of interest
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